Skip to main content
. 2015 Nov 17;12(5):1000–1007. doi: 10.5114/aoms.2015.54791

Table I.

Characteristics of patients with chronic atrial fibrillation

Variable N = 110 TF(+)
n = 16
TF(–)
n = 94
FXIa(+)
n = 16
FXIa(–)
n = 94
FIXa(+)
n = 28
FIXa(–)
n = 81
Age [years] 63.0 (55.0; 70.0) 60.0 (52.0; 67.8) 63.0 (56.0; 70.3) 57.0 (50.3; 69.8) 63.5 (56.8; 70.0) 61.5 (53.3; 66.8) 64.0 (55.0; 71.5)
Male gender, n (%) 57 (51.8) 8 (50.0) 49 (52.1) 7 (43.8) 50 (53.2) 20 (71.4)* 37 (45.7)
BMI [kg/m2] 29.1 (26.6; 31.4) 30.7 (26.9; 32.2) 29.0 (26.3; 31.2) 27.1 (25.1; 32.0) 29.2 (26.8; 31.2) 31.8 (26.4; 35.5)* 28.4 (26.6; 30.6)
Hypertension, n (%) 65 (59.1) 4 (25.0)* 61 (64.9) 6 (37.5) 59 (62.8) 19 (67.9) 46 (56.8)
CAD, n (%) 15 (13.6) 3 (18.8) 12 (12.8) 4 (25.0) 11 (11.7) 7 (25.0) 8 (9.9)
Diabetes, n (%) 6 (5.5) 2 (12.5) 4 (4.3) 2 (12.5) 4 (4.3) 1 (3.6) 5 (6.2)
Heart failure, n (%) 20 (18.2) 1 (6.3) 19 (20.2) 1 (6.3) 19 (20.2) 7 (25.0) 13 (16.0)
Smoking, n (%) 44 (40.0) 2 (12.5)* 42 (44.7) 2 (12.5)* 42 (44.7) 10 (35.7) 34 (42.0)
CHADS2 ≥ 2 points 27 (24.5) 3 (18.8) 25 (25.5) 4 (25.0) 23 (24.5) 7 (25.0) 20 (24.7)
CHADS2 1 point 47 (42.7) 2 (12.5)* 45 (47.9) 2 (12.5)* 45 (47.9) 15 (53.6) 32 (39.5)
CHA2DS2-VASc ≥ 2 points, n (%) 64 (58.2) 5 (31.3)* 59 (62.8) 6 (37.5) 58 (61.7) 16 (57.1) 48 (59.3)
CHA2DS2-VASc 1 point, n (%) 37 (33.6) 9 (56.3)* 28 (29.8) 8 (50.0) 29 (30.9) 9 (32.1) 27 (33.3)
Aspirin, n (%) 35 (31.8) 9 (56.2)* 26 (27.7) 12 (75.0)* 23 (24.5) 12 (42.9) 22 (27.2)
Statin, n (%) 53 (48.2) 1 (6.3)* 52 (55.3) 4 (25.0) 49 (52.1) 10 (35.7) 43 (53.1)
Total cholesterol [mM] 5.05 (4.17; 5.62) 5.01 (4.62; 5.89) 5.05 (4.01; 5.61) 4.83 (4.05; 5.49) 5.08 (4.18; 5.65) 5.25 (3.91; 5.87) 5.03 (4.19; 5.59)
LDL cholesterol [mM] 2.91 (2.36; 3.40) 3.02 (2.51; 3.38) 2.86 (2.36; 3.40) 3.00 (2.34; 3.10) 2.86 (2.38; 3.43) 2.95 (2.22; 3.79) 2.88 (2.41; 3.36)
HDL cholesterol [mM] 1.46 (1.14; 1.70) 1.61 (1.21; 1.74) 1.44 (1.14; 1.69) 1.56 (1.00; 1.69) 1.45 (1.18; 1.71) 1.46 (1.15; 1.72) 1.45 (1.14; 1.70)
Triglycerides [mM] 1.15 (0.74; 1.66) 1.43 (0.64; 1.93) 1.13 (0.75; 1.58) 1.17 (0.62; 1.67) 1.13 (0.75; 1.66) 0.94 (0.67; 1.63) 1.17 (0.78; 1.69)
Glucose [mM] 4.90 (4.50; 5.20) 4.95 (4.53; 5.40) 4.87 (4.50; 5.20) 4.85 (4.43; 5.30) 4.90 (4.51; 5.20) 4.85 (4.43; 5.08) 4.90 (4.51; 5.25)
Creatinine [µM] 70.7 (60.8; 80.3) 72.5 (58.0; 85.8) 70.7 (61.0; 79.7) 62.5 (50.8; 84.0) 70.7 (61.9; 80.3) 69.5 (60.0; 79.8) 69.5 (60.0; 79.8);
INR 2.48 (2.25; 2.83) 2.50 (2.20; 2.78) 2.45 (2.25; 2.84) 2.60 (2.39; 2.92) 2.44 (2.20; 2.75) 2.40 (2.08; 2.72) 2.49 (2.30; 2.85)
VWF (%) 210.5 (169.0; 240.3) 271.0 (251.0; 279.0)* 196.5 (168.0; 231.3) 253.0 (192.8; 278.8)* 205.5 (168.0; 235.3) 222.0 (168.5; 235.8) 202.0 (169.0; 245.5)
CRP [mg/l] 2.96 (1.89; 4.44) 2.35 (1.20; 4.13) 3.01 (1.92; 4.70) 2.23 (1.20; 4.13) 3.01 (1.98; 4.51) 3.12 (2.08; 5.29) 2.98 (1.83; 4.42)
IL-6 [pg/ml] 5.55 (4.40; 7.03) 7.65 (5.50; 9.88)* 5.40 (4.30; 6.70) 6.30 (5.30; 9.33)* 5.40 (4.30; 6.83) 5.40 (4.23; 7.08) 5.60 (4.45; 6.75)
LVEF (%) 49.0 (41.2; 55.0) 52.1 (41.5; 59.7) 47.9 (40.9; 55.0) 53.0 (43.3; 59.7) 47.9 (40.4; 55.0) 51.0 (42.4; 57.9) 48.0 (40.8; 53.4)
LA [mm] 43.0 (40.0; 46.0) 44.5 (42.3; 52.8)* 43.0 (40.0; 45.0) 42.5 (38.5; 44.8) 43.0 (40.0; 46.0) 43.5 (40.0; 47.0) 43.0 (40.5; 45.0)

Values are presented as median and quartiles or as percentages.

*

Values of p < 0.05 versus a subgroup without the factor tested.